 Founded
in 1907, the American Association for Cancer Research (AACR),
is a scientific society of over 15,000 laboratory and clinical
cancer researchers. It facilitates the communication and dissemination
of knowledge among scientists and others dedicated to the
cancer problem, as well as fosters research in cancer and
related biomedical sciences, to encourage presentation
and discussion of new and important observations in the field.
It also fosters public education, science education, and training;
to advance the understanding of cancer etiology, prevention,
diagnosis, and treatment throughout the world.
The 92nd AACR Annual Conference
New Orleans, Louisiana, March 24-28, 2001
Scientists from all over world who attended the recently
concluded Conference received with great interest the presentation
by Dr. Sylvain Baruchel and Dr. Bikul Das of the Hospital
for Sick Children. The highlights of the presentation were
as follows:
1. Squalene iP6 can inhibit the growth of neuroblastoma,
the third most common cancer found in children. The neuroblastoma
is a dreaded cancer that continues to kill many children every
year. The findings have provided hope for the effective treatment
of the neuroblastoma.
2. Squalene iP6 can stimulate human bone marrow stem cell
growth. Thus it may be used as an adjunct in bone marrow failure
following cancer chemotherapy. Many children exposed to cancer
drugs suffer from severe bone marrow failure leading to death.
With Squalene iP6, the success rate of bone marrow transplantation
is increased.
3. Squalene iP6 has the potential to reduce the side effects
of cancer drugs, mainly Cisplatin, an important cancer drug
that has many side effects.
Squalene iP6 is the exclusive formula high purity Squalene
supplied by the Issho Genki Corporation.
 
|
